$DRRX DURECT CORP Insider Trading
Get free email notifications about insider trading in DURECT CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in DURECT CORP. Insider overview, share value development, latest insider transactions and email notifications about new events in DURECT CORP for free.
IRS Number: 943297098
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: DRRX
Company Address: 10260 BUBB ROAD CUPERTINO 95014
DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.
Market Capitalization: $139.97M
Prev close: $1.03
Average Daily Volume: 554,829
Days Low: $0.98
Year Low: $0.98
Year High: $2.00
DURECT CORP Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 16 2021 | DRRX | DURECT CORP | BENITO SIMON X | Director | Option Exercise | A | 1.66 | 55,000 | 91,300 | 55,000 | |
May 17 2021 | DRRX | DURECT CORP | Joice Judy R | Sr. VP Operations & ... | Option Exercise | M | 0.78 | 40,137 | 31,307 | 0 | |
May 17 2021 | DRRX | DURECT CORP | Joice Judy R | Sr. VP Operations & ... | Option Exercise | M | 0.73 | 20,000 | 14,600 | 0 | |
May 17 2021 | DRRX | DURECT CORP | Joice Judy R | Sr. VP Operations & ... | Sell | S | 1.72 | 60,137 | 103,682 | 34,832 | 95 K to 34.8 K (-63.32 %) |
May 17 2021 | DRRX | DURECT CORP | Joice Judy R | Sr. VP Operations & ... | Buy | M | 0.78 | 40,137 | 31,307 | 94,969 | 54.8 K to 95 K (+73.20 %) |
May 17 2021 | DRRX | DURECT CORP | Joice Judy R | Sr. VP Operations & ... | Buy | M | 0.73 | 20,000 | 14,600 | 54,832 | 34.8 K to 54.8 K (+57.42 %) |
Jan 19 2021 | DRRX | DURECT CORP | Sussman Norman | Chief Medical Offic ... | Option Exercise | A | 2.03 | 100,000 | 203,000 | 100,000 | |
Jan 19 2021 | DRRX | DURECT CORP | Joice Judy R | Sr. VP Operations & ... | Option Exercise | A | 2.03 | 79,000 | 160,370 | 79,000 | |
Jan 19 2021 | DRRX | DURECT CORP | BROWN JAMES E | President & CEO | Option Exercise | A | 2.03 | 209,000 | 424,270 | 209,000 | |
Jan 19 2021 | DRRX | DURECT CORP | Arenberg Michael | Chief Financial Off ... | Option Exercise | A | 2.03 | 116,000 | 235,480 | 116,000 | |
Jan 05 2021 | DRRX | DURECT CORP | AZAB MOHAMMAD | Director | Option Exercise | A | 2.10 | 70,000 | 147,000 | 70,000 | |
Nov 04 2020 | DRRX | DURECT CORP | Sussman Norman | Chief Medical Offic ... | Option Exercise | A | 1.77 | 200,000 | 354,000 | 200,000 | |
Sep 02 2020 | DRRX | DURECT CORP | Bleichroeder LP | 10% Owner | Sell | S | 1.68 | 250,000 | 420,000 | 26,414,656 | 26.7 M to 26.4 M (-0.94 %) |
Jun 19 2020 | DRRX | DURECT CORP | Robertson Judith J. | Director | Option Exercise | A | 2.33 | 55,000 | 128,150 | 55,000 | |
Jun 18 2020 | DRRX | DURECT CORP | HOFFMANN DAVE | Director | Option Exercise | A | 2.33 | 55,000 | 128,150 | 55,000 |